• Black Cumin SAP may be used to support healthy cholesterol levels, mitigate or manage signs and symptoms of metabolic syndrome,[4, 14, 15, 16, 17] and improve hepatic function.[4, 5]
• Black Cumin SAP may aid in reducing the size of some tumors and in the prevention of cancer.[6, 9, 12 ]
Each softgel contains:
Black cumin (Nigella sativa) seed oil 500 mg
50% linoleic acid — 20% oleic acid
Nonmedicinal ingredients: Mixed tocopherols in a softgel made of gelatin, glycerin, and purified water
Contains no: Preservatives, artificial flavor or color, sugar, dairy, starch, wheat, gluten, yeast, citrus, or eggs.
Black cumin seed (Nigella sativa) is an herb native to the Middle Eastern and South-Asian regions of the world, and has long been used in traditional healing systems for a variety of treatments. Ayurvedic medicine as well as Unani practices demonstrate the uses of black cumin seed against diseases and conditions related to inflammation, obesity, and hypercholesterolemia. When following a supplemental dose of N. sativa daily, patient trials have resulted in lowered levels of total cholesterol and LDL-C, as well as higher levels of HDL-C, providing measurable verification of the herb's therapeutic qualities. Today, many practitioners are finding black cumin to be a potent herb in adjunctive cancer treatment. Recent studies and clinical experimentation have demonstrated the positive effects of black cumin in the prevention of cancer via free-radical scavenging and promotion of apoptosis. These seeds contain a number of substances attributed to their healing potential, including thymoquinone, saponins, alkaloids, and high levels of beneficial fatty acids including linoleic acid and oleic acid.
Take 2 softgels twice daily with food or as directed by your health care practitioner. Take a few hours before or after taking supplements containing iron, zinc, calcium, or copper. Consult a health care practitioner for use beyond 4 weeks.
Consult a health care practitioner prior to use if you have a known immune disorder. Discontinue use if you experience gastrointestinal upset, as this product may cause gastrointestinal upset when taken on an empty stomach. Do not take if you are pregnant, breast-feeding, or trying to conceive.
1. Randhawa, M.A. and M.S. Alghamdi. “Anticancer activity of Nigella sativa (black seed) — a review”. The American Journal of Chinese Medicine Vol. 39, No. 6 (2011): 1075–1091.
2. Shabana, A., et al. “Cardiovascular benefits of black cumin (Nigella sativa)”. Cardiovascular Toxicology Vol. 13, No. 1 (2013): 9–21.
3. Ali, B.H. and G. Blunden. “Pharmacological and toxicological properties of Nigella sativa”. Phytotherapy Research Vol. 17, No. 4 (2003): 299–305.
4. Sabzghabaee, A.M., et al. “Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial”. Medicinski Arhiv Vol. 66, No. 3 (2012): 198–200.
5. Qidwai, W. “Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial”. Journal of Alternative and Complementary Medicine Vol. 15, No. 6 (2009): 639–644.
6. Vanamala, J., et al. “Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone”. Plant Foods for Human Nutrition Vol. 67, No. 2 (2012): 111–119.
7. Benhaddou-Andaloussi, A., et al. “The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content”. Evidence-Based Complementary and Alternative Medicine Vol. 2011 (2011): 538671.
8. Ahmad, A., et al. “A review on therapeutic potential of Nigella sativa: A miracle herb”. Asian Pacific Journal of Tropical Biomedicine Vol. 3, No. 5 (2013): 337–352.
9. Woo, C.C., et al. “Thymoquinone: potential cure for inflammatory disorders and cancer”. Biochemical Pharmacology Vol. 83, No. 4 (2012): 443–451.
10. Farah, I.O. “Assessment of cellular responses to oxidative stress using MCF-7 breast cancer cells, black seed (N. sativa L.) extracts and H2O2”. International Journal of Environmental Research and Public Health Vol. 2, No. 3–4 (2005): 411–419.
11. Motaghed, M., F.M. Al-Hassan, and S.S. Hamid. “Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7”. Pharmacognosy Research Vol. 5, No. 3 (2013): 200–206.
12. Khan, M.A., et al. “Anticancer activities of Nigella sativa (black cumin)”. African Journal of Traditional, Complementary, and Alternative Medicines Vol. 8, No. 5 Suppl. (2011): 226–232.
13. Zaoui, A. “Acute and chronic toxicity of Nigella sativa fixed oil”. Phytomedicine Vol. 9, No. 1 (2002): 69–74. 14. Dehkordi, F.R. and A.F. Kamkhah. “Antihypertensive effect of Nigella sativa seed extract in patients with
mild hypertension”. Fundamental & Clinical Pharmacology Vol. 22, No. 4 (2008): 447–452.
15. Bamosa, A.O., et al. “Effect of Nigella sativa seeds on the glycemic control of patients with type 2
diabetes mellitus”. Indian Journal of Physiology and Pharmacology Vol. 54, No. 4 (2010): 344–354.
16. Datau, E.A., et al. “Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in
central obese male”. Acta Medica Indonesiana Vol. 42, No. 3 (2010): 130–134.
17. Qidway, W., et al. “Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial”. Journal of Alternative and Complementary Medicine Vol. 15,
No. 6 (2009): 639–644.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.